Hasmim相关文献与解析，生知库 | 链接生命科学的每一步

SNAI1-dependent upregulation of CD73 increases extracellular adenosine release to mediate immune suppression in TNBC

SNAI1依赖性CD73上调增加细胞外腺苷释放，从而介导三阴性乳腺癌的免疫抑制。

doi:10.3389/fimmu.2022.982821

Meriem Hasmim ，Malina Xiao ，Kris Van Moer ，Akinchan Kumar ，Alexandra Oniga ，Michel Mittelbronn ，Caroline Duhem ，Anwar Chammout ，Guy Berchem ，Jean Paul Thiery ，Marianna Volpert ，Brett Hollier ，Muhammad Zaeem Noman ，Bassam Janji

Targeting HIF-1 alpha transcriptional activity drives cytotoxic immune effector cells into melanoma and improves combination immunotherapy

靶向HIF-1α转录活性可驱动细胞毒性免疫效应细胞进入黑色素瘤，并改善联合免疫疗法。

期刊:Oncogene

影响因子:7.3

doi:10.1038/s41388-021-01846-x

Lequeux, Audrey; Noman, Muhammad Zaeem; Xiao, Malina; Van Moer, Kris; Hasmim, Meriem; Benoit, Alice; Bosseler, Manon; Viry, Elodie; Arakelian, Tsolere; Berchem, Guy; Chouaib, Salem; Janji, Bassam

Targeting Cytoprotective Autophagy to Enhance Anticancer Therapies

靶向细胞保护性自噬以增强抗癌疗法

期刊:Frontiers in Oncology

影响因子:3.3

doi:10.3389/fonc.2021.626309

Xiao, Malina; Benoit, Alice; Hasmim, Meriem; Duhem, Caroline; Vogin, Guillaume; Berchem, Guy; Noman, Muhammad Zaeem; Janji, Bassam

Epithelial to Mesenchymal Transition Regulates Surface PD-L1 via CMTM6 and CMTM7 Induction in Breast Cancer

上皮间质转化通过乳腺癌中的 CMTM6 和 CMTM7 诱导调节表面 PD-L1

期刊:Cancers

影响因子:

doi:10.3390/cancers13051165

Malina Xiao, Meriem Hasmim, Audrey Lequeux, Kris Van Moer, Tuan Zea Tan, Christine Gilles, Brett G Hollier, Jean Paul Thiery, Guy Berchem, Bassam Janji, Muhammad Zaeem Noman

Lighting up the fire in cold tumors to improve cancer immunotherapy by blocking the activity of the autophagy-related protein PIK3C3/VPS34

通过阻断自噬相关蛋白PIK3C3/VPS34的活性，点燃冷肿瘤中的“火焰”，从而改善癌症免疫疗法。

期刊:Autophagy

影响因子:14.3

doi:10.1080/15548627.2020.1815439

Janji, Bassam; Hasmim, Meriem; Parpal, Santiago; De Milito, Angelo; Berchem, Guy; Noman, Muhammad Zaeem

Inhibition of Vps34 reprograms cold into hot inflamed tumors and improves anti-PD-1/PD-L1 immunotherapy

抑制Vps34可将冷肿瘤重编程为热炎症肿瘤，并改善抗PD-1/PD-L1免疫疗法。

期刊:Science Advances

影响因子:11.7

doi:10.1126/sciadv.aax7881

Muhammad Zaeem Noman ，Santiago Parpal ，Kris Van Moer ，Malina Xiao ，Yasmin Yu ，Jenny Viklund ，Angelo De Milito ，Meriem Hasmim ，Martin Andersson ，Ravi K Amaravadi ，Jessica Martinsson ，Guy Berchem ，Bassam Janji

Firing up the cold tumors by targeting Vps34

通过靶向Vps34激活冷肿瘤

期刊:Oncoimmunology

影响因子:6.3

doi:10.1080/2162402X.2020.1809936

Janji, Bassam; Hasmim, Meriem; Parpal, Santiago; Berchem, Guy; Noman, Muhammad Zaeem

Improving Cancer Immunotherapy by Targeting the Hypoxic Tumor Microenvironment: New Opportunities and Challenges

通过靶向乏氧肿瘤微环境改善癌症免疫疗法：新的机遇与挑战

期刊:Cells

影响因子:5.2

doi:10.3390/cells8091083

Noman, Muhammad Zaeem; Hasmim, Meriem; Lequeux, Audrey; Xiao, Malina; Duhem, Caroline; Chouaib, Salem; Berchem, Guy; Janji, Bassam

Expression of CD94 by ex vivo-differentiated NK cells correlates with the in vitro and in vivo acquisition of cytotoxic features

体外分化的NK细胞表达CD94与体外和体内细胞毒性特征的获得相关。

期刊:Oncoimmunology

影响因子:6.3

doi:10.1080/2162402X.2017.1346763

Hasmim, Meriem; Khalife, Nadine; Zhang, Yanyan; Doldur, Manale; Visentin, Geralidne; Terry, Stéphane; Giron-Michel, Julien; Tang, Ruoping; Delhommeau, François; Dulphy, Nicolas; Bourhis, Jean-Henri; Louache, Fawzia; Chouaib, Salem

A role for EMT in CD73 regulation in breast cancer

EMT在乳腺癌CD73调控中的作用

SNAI1-dependent upregulation of CD73 increases extracellular adenosine release to mediate immune suppression in TNBC

SNAI1依赖性CD73上调增加细胞外腺苷释放，从而介导三阴性乳腺癌的免疫抑制。

Targeting HIF-1 alpha transcriptional activity drives cytotoxic immune effector cells into melanoma and improves combination immunotherapy

靶向HIF-1α转录活性可驱动细胞毒性免疫效应细胞进入黑色素瘤，并改善联合免疫疗法。

Targeting Cytoprotective Autophagy to Enhance Anticancer Therapies

靶向细胞保护性自噬以增强抗癌疗法

Epithelial to Mesenchymal Transition Regulates Surface PD-L1 via CMTM6 and CMTM7 Induction in Breast Cancer

上皮间质转化通过乳腺癌中的 CMTM6 和 CMTM7 诱导调节表面 PD-L1

Lighting up the fire in cold tumors to improve cancer immunotherapy by blocking the activity of the autophagy-related protein PIK3C3/VPS34

通过阻断自噬相关蛋白PIK3C3/VPS34的活性，点燃冷肿瘤中的“火焰”，从而改善癌症免疫疗法。

Inhibition of Vps34 reprograms cold into hot inflamed tumors and improves anti-PD-1/PD-L1 immunotherapy

抑制Vps34可将冷肿瘤重编程为热炎症肿瘤，并改善抗PD-1/PD-L1免疫疗法。

Firing up the cold tumors by targeting Vps34

通过靶向Vps34激活冷肿瘤

Improving Cancer Immunotherapy by Targeting the Hypoxic Tumor Microenvironment: New Opportunities and Challenges

通过靶向乏氧肿瘤微环境改善癌症免疫疗法：新的机遇与挑战

Expression of CD94 by ex vivo-differentiated NK cells correlates with the in vitro and in vivo acquisition of cytotoxic features

体外分化的NK细胞表达CD94与体外和体内细胞毒性特征的获得相关。